Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Poll






Aug 01, 2013

GSK China Scandal

Chinese officials have detained 22 GlaxoSmithKline (GSK) employees and an unknown number of doctors in the last month, accusing them of misdeeds and bribery. The company is one of about 60 biopharmas currently under investigation by Beijing for pricing policies. (Learn more here.) Do you expect this scandal will have a lasting effect on China’s biopharma industry?

What long-term effect will the GSK scandal have on the biopharma industry in China?

No effect
 
  12.7%
Little effect
 
  40.7%
A big effect
 
  32.0%
Get out now, while you have the chance!
 
  14.7%



Related content